1Lozo P,Krpan D,Krvavica A,et al. Bone histology in postmenopausal osteoporosis-variations in cellular activity[J]. Acta MED Croatica, 2004,58 (1):5-11.
2Nakamura T,Imai Y,Matsumoto T,et al. Estrogen prevents bone loss via estrogen receptor alpha and Induction of Fas Ligand in Osteoclasts [J]. Cell, 2007,130(5 ) : 811-823.
5Mann V,Huber C, Kogianni G,et al. The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro[J]. Bone, 2007,40 (3) : 674-684.
二级参考文献6
1Kasukawa Y, Stabnov L, Miyakoshi N, et al. Insulin - like growth factor I effect on the number of osteoblast progenitors is impaired in ovariectomized mice. J Bone Miner Res, 2002,17(9):1579
2Kassem M, Okazki R, Harris SA, et al. Estrogen effects in insulin- like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int, 1998,62(1) : 602
3Posaci C, Altunyurt S, Islekel H,et al.Effects of HRT on serum levels of IGF- I in postmenopausal women. Maturitas,2001,40(1) :69
4Seck T, Scheidt- Nave C, Leidig- Bruckner G. Low serrum concentrations of insulin - like factor I are associated with femoral bone loss in a population- based sample of postmenopausal womem. Clin Endocrinol(Oxf), 2001,55:101
5Gamero P, Somay- Rendu E, Delmas PD. Low serum IGF- I and occurrence of osteoporotic fractures in postmenopausal women (letter).Lancet, 2000,355(9207) :898
